Paper-cut illustration of a weekly injection pen beside a blank wall calendar with four highlighted squares and a floating molecule

Tirzepatide Hub · FormBlends network

Get the tirzepatide dates, units and costs right, with the label behind every number.

For anyone on tirzepatide or thinking about it: when each dose step is allowed, how many units a vial dose is, what to do about a missed dose, and what it costs.

20 weeks
label-minimum escalation from 2.5 mg to 15 mg
The shortest the label allows to climb from the starting dose to the top dose.
96 hours
missed-dose window; 72 hours to change injection day
How long you have to take a missed dose before you skip it and wait for the next.
$299 / $399 / $449
LillyDirect vial self-pay tiers
Lilly's own self-pay vial prices by dose, so you can compare any other offer.

Reading

Start with these

Each page opens with a plain-English summary, a figure drawn from the data, the numbers that matter, and what it means if you're considering treatment.

Compare

Mounjaro vs Zepbound: same molecule, two labels

You'll get: Mounjaro and Zepbound are the same drug, tirzepatide, sold under two names for different approved uses.

Where the Mounjaro and Zepbound labels agree (dosing, missed doses, strengths, storage) and where they differ (approved uses, dates, trials, side effects).

Updated September 4, 2026
Paper-cut illustration of two injection pens side by side, one terracotta and one green

Compare

Tirzepatide vs semaglutide: what the head-to-head trial showed

You'll get: One trial compared the two drugs head to head for 72 weeks in 751 adults with obesity and no diabetes.

SURMOUNT-5 compared tirzepatide and semaglutide head to head for 72 weeks. The weight results, the main caveats, and how the doses and prices line up.

Updated September 4, 2026
Paper-cut illustration of coins stacked into three columns with a blank paper price tag

Costs

Zepbound self-pay prices: every Lilly price with its date

You'll get: Lilly's cash price for Zepbound vials is 299, 399 or 449 dollars for four weekly doses, depending on strength.

The list price at launch, the LillyDirect vial prices at each change since August 2024, the KwikPen self-pay tiers, and a cost tracker that turns them into cost per injection, per milligram and per year.

Updated September 4, 2026
Paper-cut illustration of a syringe with plain tick marks beside a slide rule and a ruler

Guides

The tirzepatide titration schedule, step by step, with dates

You'll get: Titration, the step-up in dose, starts at 2.5 mg and rises by 2.5 mg after at least four weeks per step.

What the Zepbound and Mounjaro labels say about starting at 2.5 mg, moving up in 2.5 mg steps, and which doses count as maintenance. Plus a planner that turns the rules into calendar dates.

Updated September 4, 2026
Paper-cut illustration of a syringe with plain tick marks beside a slide rule and a ruler

Guides

Missed a tirzepatide dose? The 96-hour rule and the 72-hour rule

You'll get: The label says a dose up to four days late can still be taken, and your usual day does not move.

Exactly what the Zepbound and Mounjaro labels say about a late dose, a skipped dose, and changing your injection day, with worked examples and a helper that applies the rules to your times.

Updated September 4, 2026

Live updates

What changed since this site was written

Sources checked October 23, 2026, refreshed every six hours.

Compounded price index

Median all-in cash price per 28 days across providers, as of September 3, 2026.

semaglutide, month 1 at 0.25 mg/week
$197
median of 14 providers
semaglutide, month 4 at 1 mg/week
$199
median of 13 providers
tirzepatide, month 1 at 2.5 mg/week
$268
median of 14 providers
tirzepatide, month 4 at 5 mg/week
$299
median of 12 providers
  • September 3, 2026: Index, All, baseline 51 rows. First weekly snapshot. Changes against this baseline will be listed here with the date they were observed.
Index methodology

PubMed lists come from NCBI E-utilities and are not reviewed by us before they appear. Feeds are FormBlends Research data (CC BY 4.0); FormBlends sells compounded GLP-1 drugs and appears in the price index under the same rules as every other provider. Compounded drugs are not FDA approved.

Why a whole site for one drug

Tirzepatide has two brand labels (Mounjaro for type 2 diabetes since May 13, 2022; Zepbound for weight reduction since November 8, 2023 and for obstructive sleep apnea since December 20, 2024), six strengths, four presentations, a 20-week label-minimum escalation, a 96-hour missed-dose window, a 72-hour day-change rule and a price list that Lilly has changed three times since August 2024. Each of those facts is small. Together they generate most of the questions people actually have. This site answers them one page at a time, with the label section or PubMed id next to every number.

What this site will not do

It will not tell you what dose to take or when to move up. The tools take the dose from your prescription and do arithmetic on dates, volumes and prices. Compounded tirzepatide is not FDA approved and is not interchangeable with Zepbound or Mounjaro; where a page discusses it, that is said plainly. There are no reviews, testimonials, or star ratings here, and no clinician bylines. The byline is the FormBlends editorial team, which also runs formblends.com, a GLP-1 program with a commercial interest disclosed on every page.